METHOD FOR PREPARING CHIRAL INTERMEDIATES FOR PREPARATION OF HMG-COA REDUCTASE INHIBITORS
    1.
    发明申请
    METHOD FOR PREPARING CHIRAL INTERMEDIATES FOR PREPARATION OF HMG-COA REDUCTASE INHIBITORS 审中-公开
    制备HMG-COA还原酶抑制剂的CHIRAL中间体的方法

    公开(公告)号:WO2009139593A2

    公开(公告)日:2009-11-19

    申请号:PCT/KR2009002573

    申请日:2009-05-14

    IPC分类号: C07D307/06

    CPC分类号: C07D319/06

    摘要: The present invention relates to a method for the commercial mass production of t-butyl (2,2-dimethyl-6-hydroxymethyl-[1,3]dioxane-4-yl) acetate having an optical activity, which is a core intermediate in the preparation of a variety of HMG-CoA reductase inhibitors, and to novel intermediates for the same. According to the preparation method of the present invention, t-butyl (2,2-dimethyl-6-hydroxymethyl-[1,3]dioxane-4-yl) acetate having an optical activity can be prepared in an economically advantageous and effective manner.

    摘要翻译: 本发明涉及一种商业化生产具有光学活性的叔丁基(2,2-二甲基-6-羟甲基 - [1,3]二恶烷-4-基)乙酸酯的方法,其为核心中间体 制备各种HMG-CoA还原酶抑制剂,以及与其相同的新型中间体。 根据本发明的制备方法,可以以经济上有利且有效的方式制备具有光学活性的(2,2-二甲基-6-羟甲基 - [1,3]二恶烷-4-基)乙酸叔丁酯 。